Transzend Scientific Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 10.00 K
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 46.45%
- Profit Growth 213.02%
- Ebitda -44.94%
- Net Worth 81.21%
- Total Assets 120.17%
About Transzend Scientific
Transzend Scientific Private Limited (TSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 17 October 2020 (Four years and three months 25 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Manuel Vincentraja and Helen Victoria serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33100KA2020PTC139883
-
Company No.
139883
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Oct 2020
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Transzend Scientific?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manuel Vincentraja
|
Director | 17-Oct-2020 | Current |
|
Helen Victoria
|
Director | 17-Oct-2020 | Current |
Financial Performance of Transzend Scientific.
Transzend Scientific Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.45% increase. The company also saw a substantial improvement in profitability, with a 213.02% increase in profit. The company's net worth Soared by an impressive increase of 81.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Transzend Scientific?
Unlock access to Transzend Scientific's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Transzend Scientific?
Transzend Scientific has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Transzend Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transzend Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.